Seven questions for Congress

With all the obsession over who will take over the White House in 2009, it's easy to forget that November will see linkurl:hundreds of other;http://www.the-scientist.com/article/display/54458/ US national elections. These will concern Congress, and could have major impacts on science policy. To that end, linkurl:Scientists and Engineers for America and 15 other societies;http://sefora.org/2008/06/19/action-alert-ask-your-congressman-about-science-today/ have sent linkurl:seven questions;http://

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
With all the obsession over who will take over the White House in 2009, it's easy to forget that November will see linkurl:hundreds of other;http://www.the-scientist.com/article/display/54458/ US national elections. These will concern Congress, and could have major impacts on science policy. To that end, linkurl:Scientists and Engineers for America and 15 other societies;http://sefora.org/2008/06/19/action-alert-ask-your-congressman-about-science-today/ have sent linkurl:seven questions;http://sharp.sefora.org/innovation2008/#questions related to linkurl:science and technology policy;http://www.the-scientist.com/blog/display/54178/ to all candidates who have survived the primaries. Some linkurl:candidates;http://sharp.sefora.org/people/house/danny-davis/ have already responded. You can check the SEA Web site to see if linkurl:your candidates;http://sharp.sefora.org/find-your-candidates/ have answered, too. If not, you can bug them.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies